A TRIF-biased TLR4 agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Lipid A Monophosphoryl from Salmonella minnesota R595

Item No. 25848

Technical Information
Formulation
A lyophilized powder
Shipping & Storage Information
Storage
4°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Visit Our Environmental Toxicology Resource Center

    Explore additional resources to study natural toxins, pollutants including PFAS and 6-PPD-Q, and their biological effects.

    ENVIRONMENTAL TOXICOLOGY TOOLS & SERVICES
    Product Description

    Lipid A monophosphoryl from Salmonella minnesota R595 is a non-toxic fragment of lipopolysaccharide (LPS) extracted from wild-type S. minnesota R595 and a TRIF biased toll-like receptor 4 (TLR4) agonist.1 Lipid A monophosphoryl induces T cell clonal expansion and TRIF-dependent production of G-CSF, IL-10, IP-10, and MCP-1 but has no effect on MyD88-dependent production of the inflammatory cytokines IL-1β, IL-6, MIP-1α, and IFN-γ in mice, indicating decreased potential for inflammatory toxicity compared to LPS and use as a non-toxic vaccine adjuvant.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mata-Haro, V., Cekic, C., Martin, M., et alThe vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316(5831), 1628-1632 (2007).